Paper Details

  1. Home
  2. Paper Details

Carfilzomib-induced life-threatening lung injury in refractory multiple myeloma.

Author: AlshurafaAwni, BenkhadraMaria, ElsabahHesham, GhasoubRola, KassemNancy

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Carfilzomib is a proteasome inhibitor used to treat multiple myeloma. While carfilzomib is associated with respiratory side effects, severe pulmonary toxicity is rare and only reported in a few case reports.
Paper Details　
Original Abstract of the Article :
Carfilzomib is a second-generation selective proteasome inhibitor that is commonly used in the treatment of relapsed or refractory multiple myeloma. Carfilzomib is associated with respiratory side effects, such as cough, dyspnea, and upper respiratory tract infection. However, severe pulmonary toxic...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/10781552231190039

データ提供：米国国立医学図書館（NLM）

Navigating the Risks of Carfilzomib: A Cautionary Tale in Multiple Myeloma Treatment

Carfilzomib, a powerful drug used to treat multiple myeloma, has proven effective in battling this complex disease. However, as with many potent therapies, there are potential side effects to consider. This research delves into a rare but serious complication associated with carfilzomib: life-threatening lung injury. It’s like uncovering a hidden danger in the vast landscape of cancer treatment.

A Rare But Serious Side Effect

While carfilzomib is generally well-tolerated, the authors highlight the importance of recognizing and managing this potentially life-threatening complication. The case report underscores the need for vigilance and early intervention to minimize the risk of severe pulmonary toxicity. It’s like navigating a treacherous path, remaining alert to potential hazards and prepared to take immediate action when necessary.

Balancing Benefits and Risks in Cancer Treatment

This research emphasizes the importance of careful risk-benefit assessment when using powerful therapies like carfilzomib. While the drug can be highly effective in treating multiple myeloma, healthcare professionals must remain vigilant in monitoring for potential complications, ensuring the best possible outcomes for patients. It’s like carefully navigating a path through a minefield, understanding the potential dangers and taking appropriate precautions to ensure safety.

Dr. Camel’s Conclusion

This case report highlights the potential risks associated with even the most promising cancer therapies. It’s like finding a hidden trap in the vast desert of cancer treatment, reminding us of the importance of vigilance and careful monitoring. By understanding the potential side effects of these powerful drugs, healthcare professionals can better manage patient care and ensure the best possible outcomes, navigating the challenges of cancer treatment with greater awareness and caution.

Date :
  1. Date Completed 2023-12-06
  2. Date Revised 2023-12-06
Further Info :

Pubmed ID

37489075

DOI: Digital Object Identifier

10.1177/10781552231190039

Related Literature

Article Analysis
・Side Effects of hydrocortisone
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.